Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
2,545,792
-
Shares change
-
+1,437,268
-
Total reported value, excl. options
-
$28,051,606
-
Value change
-
+$16,117,958
-
Put/Call ratio
-
267%
-
Number of buys
-
26
-
Number of sells
-
-10
-
Price
-
$11.02
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2019
41 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,545,792 shares
of 33,289,095 outstanding shares and own 7.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (722,760 shares), Balyasny Asset Management LLC (271,947 shares), Sofinnova Investments, Inc. (261,391 shares), MILLENNIUM MANAGEMENT LLC (212,348 shares), GEODE CAPITAL MANAGEMENT, LLC (165,866 shares), BlackRock Inc. (104,968 shares), EAM Investors, LLC (90,350 shares), GOLDMAN SACHS GROUP INC (81,317 shares), BARCLAYS PLC (79,544 shares), and Tibra Equities Europe Ltd (68,047 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.